Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Donor-Derived Ex-Vivo Expanded Natural Killer Cell Infusions in Children and Young Adults With High Risk Acute Myeloid Leukemia Receiving Myeloablative HLA-Haploidentical Hematopoietic Cell TransplantHemic and Lymphatic Diseases, Neoplasms by Histologic Type, acute myeloid leukemia, hematologic disorder, leukemia, myeloid leukemia, neoplasmEnrolling by invitationPhase 22025-05-04NCT04836390

3 results · Page 1 of 1

Swipe the table sideways for more columns.

13 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
AdventHealth OrlandoOrlandoUnited States147
Ann & Robert H. Lurie Children's HospitalChicagoUnited States8
Children's Hospital ColoradoAuroraUnited States312
Children's Hospital Los AngelesLos AngelesUnited States226
Cleveland Clinic Lerner College of MedicineClevelandUnited States3
Fred Hutchinson Cancer CenterSeattleUnited States1
Johns Hopkins All Children's HospitalSt. PetersburgUnited States116
Medical College of WisconsinMilwaukeeUnited States483
Nationwide Children's HospitalColumbusUnited States309
New York Medical CollegeValhallaUnited States71
Phoenix Children's HospitalPhoenixUnited States95
University of UtahSalt Lake CityUnited States137
Washington University, St. LouisSt LouisUnited States10